U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 21 to 40 of 41

Tests names and labsConditionsGenes, analytes, and microbesMethods

Osteogenesis imperfecta Deletion / Duplication panel - Dominant & Recessive

HNL Genomics Connective Tissue Gene Tests
United States
3024
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Osteogenesis imperfecta Deletion / Duplication panel - Recessive

HNL Genomics Connective Tissue Gene Tests
United States
2319
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Osteogenesis imperfecta Comprehensive panel - Dominant & Recessive

HNL Genomics Connective Tissue Gene Tests
United States
3024
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Ehlers-Danlos Syndrome Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
3817
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta, Hypophosphatasia (HPP), and Inherited Hypophosphatemic Rickets Panel

PreventionGenetics, part of Exact Sciences
United States
4637
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

qCarrier Plus

Quantitative Genomic Medicine Laboratories, SL
Spain
325300
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta and Hypophosphatasia (HPP) Panel

PreventionGenetics, part of Exact Sciences
United States
3727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Osteogenesis Imperfecta and Bone Fragility Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
12065
  • D Deletion/duplication analysis

Osteogenesis Imperfecta via the P3H1 / LEPRE1 Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ehlers-Danlos Syndromes (EDS) Panel

PreventionGenetics, part of Exact Sciences
United States
9965
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Low Bone Mass Panel (MitomeNGS)

Baylor Genetics
United States
3922
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta Genetic Panel

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
2819
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta and Low Bone Density Panel, Sequencing

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
3426
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta Panel, Recessive

CNH Molecular Diagnostics Laboratory Childrens National Hospital
United States
1810
  • C Sequence analysis of the entire coding region

Osteogenesis imperfecta: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
1817
  • C Sequence analysis of the entire coding region

OSTEOGENESIS IMPERFECTA (AUTOSOMAL RECESSIVE)

Laboratorio de Genetica Clinica SL
Spain
99
  • C Sequence analysis of the entire coding region

Osteogenesis imperfecta and related skeletal dysplasias with decreased bone density panel

CeGaT GmbH
Germany
2327
  • C Sequence analysis of the entire coding region

Potentially lethal skeletal disorders Panel

CeGaT GmbH
Germany
4544
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta type VIII

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Osteogenesis Imperfecta and Genetic Bone Disorders Panel

Collagen Diagnostic Laboratory University of Washington
United States
2730
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 21 to 40 of 41

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.